INVESTIGATION OF THE 24 HOUR FORCED EXPIRATORY FLOW IN 1 SECOND (FEV1) PROFILE OF A SINGLE DOSE OF INDACATEROL/MOMETASONE DELIVERED VIA THE TWISTHALER® DEVICE IN ADULT PATIENTS WITH PERSISTENT ASTHMA: